SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999.
SDIX (Nasdaq: SDIX) Trading at $2.94, Up $1.08. Today announced that its RapidChek SELECT test system has been reviewed by the U.S. Food and Drug Administration (FDA) and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing. For pooled egg testing, SDIX’s method is considered by FDA as equivalent to its standard test without a 96-hour hold period, thus delivering results with a substantial time and cost advantage.
Recently, SDIX’s test also earned Performance-Tested Methods (PTM) certification from the AOAC Research Institute (AOAC-RI). The AOAC PTM certification also validated the RapidChek SELECT SE method as equivalent to the FDA methodology for detecting SE in poultry house environments and pooled eggs. With the added FDA equivalency determination, SDIX’s test can help the approximately 3,300 egg producers comply with the new FDA regulations and significantly reduce contamination levels from those being experienced today by providing a more sensitive and accurate detection of SE.
What They Do: SDIX is a biotechnology company delivering advanced immuno-solutions and critical reagents to the life science sector.
Zale Corporation (NYSE: ZLC) Trading at $5.47, Up $1.44. Announced Tuesday after market close that comparable store sales increased 8.5% for the combined months of November and December 2010, encompassing the entire holiday selling period. Within this two-month period, November same store sales increased 11.5% and December same store sales increased 7.4%. At constant exchange rates, which excludes the effect of translating Canadian currency denominated sales into U.S. dollars, comparable store sales increased 7.6% for the holiday selling period. Total revenues for the two-month period were $533.1 million compared to $493.7 million last year, an increase of 8.0%.
Holiday selling period comparable store sales detail: U.S. Fine Jewelry brands, consisting of Zales Jewelers, Zales Outlet and Gordon’s Jewelers, had an increase in same store sales of 7.5%. Canadian Fine Jewelry brands, consisting of Peoples Jewellers and Mappins Jewellers, had an increase in same store sales of 15.6% (an increase of 10.2% at constant exchange rates). Kiosk Jewelry same store sales increased 4.2%.
What They Do: Zale Corporation is a leading specialty retailer of diamonds and other jewelry products in North America, operating approximately 1,900 retail locations throughout the United States, Canada and Puerto Rico, as well as online.
China Direct Industries (Nasdaq: CDII) Trading at $1.72, Up $0.23. Today announced that its magnesium segment operations received new purchase contracts valued at approximately $31 million in its first quarter of fiscal 2011, ended December 31, 2010. Deliveries of these new orders began in the first quarter of fiscal 2011 and are expected to be completed by the third quarter of fiscal 2011.
The $31 million in new contracts consisted of direct purchases from new and existing customers including three major Fortune 500 companies. Additionally, the efforts of our direct marketing company International Magnesium Group or "IMG" and its branding efforts made a significant contribution to these contracts. Management sees these new contract wins as continuing evidence of an improving overall demand for its magnesium products and recognition of its branding initiative.
What They Do: China Direct Industries is a U.S. owned holding company operating in China in two core business segments, pure magnesium production and distribution and distribution of basic materials in China.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit www.SmallCapReview.com.
